{"count": 12, "results": [{"_id": "6661351", "pmid": 6661351, "title": "Increased platelet adhesion and aggregation in hypertensive patients: effect of atenolol.", "journal": "Br J Clin Pharmacol", "authors": ["Markel A", "Brook JG", "Levy Y", "Aviram M", "Youdim MB"], "date": "1983-12-01T00:00:00Z", "doi": "10.1111/j.1365-2125.1983.tb02238.x", "meta_date_publication": "1983 Dec", "meta_volume": "16", "meta_issue": "6", "meta_pages": "663-8", "score": 50074.883, "text_hl": "Increased @<m>DISEASE_Blood_Platelet_Disorders</m> @DISEASE_MESH:D001791 @@@platelet adhesion and aggregation@@@ in @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ @SPECIES_9606 @@@patients@@@: effect of @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@.", "citations": {"NLM": "Markel A, Brook JG, Levy Y, Aviram M, Youdim MB. Increased platelet adhesion and aggregation in hypertensive patients: effect of atenolol. Br J Clin Pharmacol. 1983 Dec;16(6):663-8. PMID: 6661351", "BibTeX": "@article{6661351, title={Increased platelet adhesion and aggregation in hypertensive patients: effect of atenolol.}, author={Markel A and Brook JG and Levy Y and Aviram M and Youdim MB}, journal={Br J Clin Pharmacol}, volume={16}, number={6}, pages={663-8}}"}}, {"_id": "15849842", "pmid": 15849842, "title": "Effects of atenolol and propranolol on platelet aggregation in moderate essential hypertension: randomized crossover trial.", "journal": "Croat Med J", "authors": ["Punda A", "Polić S", "Rumboldt Z", "Bagatin J", "Marković V", "Lukin A"], "date": "2005-04-01T00:00:00Z", "meta_date_publication": "2005 Apr", "meta_volume": "46", "meta_issue": "2", "meta_pages": "219-24", "score": 50067.82, "text_hl": "AIM: To compare the effects of a selective beta-blocker @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ and a nonselective beta-blocker @CHEMICAL_Propranolol @CHEMICAL_MESH:D011433 @@@propranolol@@@ on @<m>DISEASE_Blood_Platelet_Disorders</m> @DISEASE_MESH:D001791 @@@platelet aggregation@@@. ", "citations": {"NLM": "Punda A, Polić S, Rumboldt Z, Bagatin J, Marković V, Lukin A. Effects of atenolol and propranolol on platelet aggregation in moderate essential hypertension: randomized crossover trial. Croat Med J. 2005 Apr;46(2):219-24. PMID: 15849842", "BibTeX": "@article{15849842, title={Effects of atenolol and propranolol on platelet aggregation in moderate essential hypertension: randomized crossover trial.}, author={Punda A and Polić S and Rumboldt Z and Bagatin J and Marković V and Lukin A}, journal={Croat Med J}, volume={46}, number={2}, pages={219-24}}"}}, {"_id": "11229106", "pmid": 11229106, "title": "Effect of prazosin GITS, atenolol, nifedipine SR, and enalapril on ADP-induced platelet aggregation.", "journal": "J Assoc Physicians India", "authors": ["Patki KC", "Joglekar SJ", "Kamat SK", "Thatte UM", "Yeolekar ME", "Rege NN", "Dahanukar SA", "Nanivadekar AS"], "date": "1998-01-01T00:00:00Z", "meta_date_publication": "1998", "meta_volume": "Suppl 1", "meta_issue": "", "meta_pages": "26-9", "score": 50066.82, "text_hl": "Effect of prazosin GITS, @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@, nifedipine SR, and @CHEMICAL_Enalapril @CHEMICAL_MESH:D004656 @@@enalapril@@@ on @GENE_WDTC1 @GENE_23038 @@@ADP@@@-induced @<m>DISEASE_Blood_Platelet_Disorders</m> @DISEASE_MESH:D001791 @@@platelet aggregation@@@.", "citations": {"NLM": "Patki KC, Joglekar SJ, Kamat SK, Thatte UM, Yeolekar ME, Rege NN, Dahanukar SA, Nanivadekar AS. Effect of prazosin GITS, atenolol, nifedipine SR, and enalapril on ADP-induced platelet aggregation. J Assoc Physicians India. 1998;Suppl 1():26-9. PMID: 11229106", "BibTeX": "@article{11229106, title={Effect of prazosin GITS, atenolol, nifedipine SR, and enalapril on ADP-induced platelet aggregation.}, author={Patki KC and Joglekar SJ and Kamat SK and Thatte UM and Yeolekar ME and Rege NN and Dahanukar SA and Nanivadekar AS}, journal={J Assoc Physicians India}, volume={Suppl 1}, pages={26-9}}"}}, {"_id": "6135813", "pmid": 6135813, "title": "Drug-induced inhibition of guinea pig platelet aggregation unrelated to their beta-adrenolytic actions.", "journal": "Jpn J Pharmacol", "authors": ["Iwamura M", "Ishimori T", "Makino M", "Yasuda K", "Izumi A", "Himori N"], "date": "1983-02-01T00:00:00Z", "doi": "10.1254/jjp.33.219", "meta_date_publication": "1983 Feb", "meta_volume": "33", "meta_issue": "1", "meta_pages": "219-26", "score": 50062.387, "text_hl": "Inhibitory actions on @CHEMICAL_Adenosine_Diphosphate @CHEMICAL_MESH:D000244 @@@adenosine diphosphate@@@ (@CHEMICAL_Adenosine_Diphosphate @CHEMICAL_MESH:D000244 @@@ADP@@@)-induced @<m>DISEASE_Blood_Platelet_Disorders</m> @DISEASE_MESH:D001791 @@@platelet aggregation@@@ of @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@, dl- and d-D-32, IPS-339, @CHEMICAL_Pindolol @CHEMICAL_MESH:D010869 @@@pindolol@@@ and @CHEMICAL_Propranolol @CHEMICAL_MESH:D011433 @@@propranolol@@@ were investigated in @SPECIES_10141 @@@guinea pigs@@@ for the purpose of obtaining a clue about a possible mechanism for the disaggregatory phenomenon of beta-adrenoceptor blocking agents. ", "citations": {"NLM": "Iwamura M, Ishimori T, Makino M, Yasuda K, Izumi A, Himori N. Drug-induced inhibition of guinea pig platelet aggregation unrelated to their beta-adrenolytic actions. Jpn J Pharmacol. 1983 Feb;33(1):219-26. PMID: 6135813", "BibTeX": "@article{6135813, title={Drug-induced inhibition of guinea pig platelet aggregation unrelated to their beta-adrenolytic actions.}, author={Iwamura M and Ishimori T and Makino M and Yasuda K and Izumi A and Himori N}, journal={Jpn J Pharmacol}, volume={33}, number={1}, pages={219-26}}"}}, {"_id": "15772518", "pmid": 15772518, "title": "Effect of manidipine as compared to atenolol on platelet aggregation in elderly patients with isolated systolic hypertension and type II diabetes mellitus.", "journal": "J Cardiovasc Pharmacol", "authors": ["Mugellini A", "Rinaldi A", "Zoppi A", "Lazzari P", "Fogari E", "Corradi L", "Fogari R"], "date": "2005-04-01T00:00:00Z", "doi": "10.1097/01.fjc.0000155387.49103.87", "meta_date_publication": "2005 Apr", "meta_volume": "45", "meta_issue": "4", "meta_pages": "310-3", "score": 50059.703, "text_hl": "No changes in @<m>DISEASE_Blood_Platelet_Disorders</m> @DISEASE_MESH:D001791 @@@platelet aggregation@@@ were observed in the @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ group. ", "citations": {"NLM": "Mugellini A, Rinaldi A, Zoppi A, Lazzari P, Fogari E, Corradi L, Fogari R. Effect of manidipine as compared to atenolol on platelet aggregation in elderly patients with isolated systolic hypertension and type II diabetes mellitus. J Cardiovasc Pharmacol. 2005 Apr;45(4):310-3. PMID: 15772518", "BibTeX": "@article{15772518, title={Effect of manidipine as compared to atenolol on platelet aggregation in elderly patients with isolated systolic hypertension and type II diabetes mellitus.}, author={Mugellini A and Rinaldi A and Zoppi A and Lazzari P and Fogari E and Corradi L and Fogari R}, journal={J Cardiovasc Pharmacol}, volume={45}, number={4}, pages={310-3}}"}}, {"_id": "21043897", "pmid": 21043897, "title": "Antiaggregatory Properties of Beta-adrenoceptor Blocking Drugs are Related to their Physico-chemical Properties.", "journal": "Platelets", "authors": ["Nosál R", "Jancinová V", "Petriková M"], "date": "1992-01-01T00:00:00Z", "doi": "10.3109/09537109209013165", "meta_date_publication": "1992", "meta_volume": "3", "meta_issue": "1", "meta_pages": "29-33", "score": 50057.65, "text_hl": "The effects of the beta-adrenoceptor blockers (BAB) @CHEMICAL_Alprenolol @CHEMICAL_MESH:D000526 @@@alprenolol@@@, @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@, @CHEMICAL_Metipranolol @CHEMICAL_MESH:D014290 @@@metipranolol@@@, @CHEMICAL_Oxprenolol @CHEMICAL_MESH:D010096 @@@oxprenolol@@@, @CHEMICAL_Practolol @CHEMICAL_MESH:D011217 @@@practolol@@@ and @CHEMICAL_Propranolol @CHEMICAL_MESH:D011433 @@@propranolol@@@ on @<m>DISEASE_Blood_Platelet_Disorders</m> @DISEASE_MESH:D001791 @@@platelet aggregation@@@ stimulated by @CHEMICAL_Adenosine_Diphosphate @CHEMICAL_MESH:D000244 @@@ADP@@@, @GENE_F2 @GENE_2147 @@@thrombin@@@ and collagen were investigated. ", "citations": {"NLM": "Nosál R, Jancinová V, Petriková M. Antiaggregatory Properties of Beta-adrenoceptor Blocking Drugs are Related to their Physico-chemical Properties. Platelets. 1992;3(1):29-33. PMID: 21043897", "BibTeX": "@article{21043897, title={Antiaggregatory Properties of Beta-adrenoceptor Blocking Drugs are Related to their Physico-chemical Properties.}, author={Nosál R and Jancinová V and Petriková M}, journal={Platelets}, volume={3}, number={1}, pages={29-33}}"}}, {"_id": "15869009", "pmid": 15869009, "title": "Carvedilol--a beta-blocker with considerable antiaggregatory effect on human blood platelets.", "journal": "Bratisl Lek Listy", "authors": ["Petrikova M", "Jancinova V", "Nosal R", "Majekova M", "Fabryova V"], "date": "2005-01-01T00:00:00Z", "meta_date_publication": "2005", "meta_volume": "106", "meta_issue": "1", "meta_pages": "20-5", "score": 50054.652, "text_hl": "CONCLUSION: Our study found @CHEMICAL_Carvedilol @CHEMICAL_MESH:D000077261 @@@carvedilol@@@ to be more potent than @CHEMICAL_Propranolol @CHEMICAL_MESH:D011433 @@@propranolol@@@ and @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ in inhibiting @<m>DISEASE_Blood_Platelet_Disorders</m> @DISEASE_MESH:D001791 @@@platelet aggregation@@@ and @CHEMICAL_Thromboxane_B2 @CHEMICAL_MESH:D013929 @@@thromboxane B2@@@ production. ", "citations": {"NLM": "Petrikova M, Jancinova V, Nosal R, Majekova M, Fabryova V. Carvedilol--a beta-blocker with considerable antiaggregatory effect on human blood platelets. Bratisl Lek Listy. 2005;106(1):20-5. PMID: 15869009", "BibTeX": "@article{15869009, title={Carvedilol--a beta-blocker with considerable antiaggregatory effect on human blood platelets.}, author={Petrikova M and Jancinova V and Nosal R and Majekova M and Fabryova V}, journal={Bratisl Lek Listy}, volume={106}, number={1}, pages={20-5}}"}}, {"_id": "20411618", "pmid": 20411618, "title": "Cardiovascular protective effects of nebivolol in Zucker diabetic fatty rats.", "journal": "J Hypertens", "authors": ["Toblli J", "Cao G", "Rivas C", "Munoz M", "Giani J", "Dominici F", "Angerosa M"], "date": "2010-05-01T00:00:00Z", "doi": "10.1097/hjh.0b013e328337598c", "meta_date_publication": "2010 May", "meta_volume": "28", "meta_issue": "5", "meta_pages": "1007-19", "score": 50049.85, "text_hl": "However, @CHEMICAL_Nebivolol @CHEMICAL_MESH:D000068577 @@@nebivolol@@@ showed a better @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@ profile, preserved left ventricular function, a significant control in left ventricular geometry and moderated @DISEASE_Hypertrophy_Left_Ventricular @DISEASE_MESH:D017379 @@@left ventricular hypertrophy@@@ versus @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@. Significant reduction in @<m>DISEASE_Blood_Platelet_Disorders</m> @DISEASE_MESH:D001791 @@@platelet aggregation@@@ and a substantial endothelium-dependent and endothelium-independent relaxation in vessels were also shown in the @CHEMICAL_Nebivolol @CHEMICAL_MESH:D000068577 @@@nebivolol@@@ group versus @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ group. ", "citations": {"NLM": "Toblli J, Cao G, Rivas C, Munoz M, Giani J, Dominici F, Angerosa M. Cardiovascular protective effects of nebivolol in Zucker diabetic fatty rats. J Hypertens. 2010 May;28(5):1007-19. PMID: 20411618", "BibTeX": "@article{20411618, title={Cardiovascular protective effects of nebivolol in Zucker diabetic fatty rats.}, author={Toblli J and Cao G and Rivas C and Munoz M and Giani J and Dominici F and Angerosa M}, journal={J Hypertens}, volume={28}, number={5}, pages={1007-19}}"}}, {"_id": "17288698", "pmid": 17288698, "title": "Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.", "journal": "Curr Med Res Opin", "authors": ["Devereux RB", "Dahlöf B"], "date": "2007-02-01T00:00:00Z", "doi": "10.1185/030079906X167435", "meta_date_publication": "2007 Feb", "meta_volume": "23", "meta_issue": "2", "meta_pages": "443-57", "score": 50042.508, "text_hl": "Thus, the observed outcomes benefits favoring @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@losartan@@@ may involve other possible mechanisms, including differential effects of @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@losartan@@@ and @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ on @DISEASE_Hypertrophy_Left_Ventricular @DISEASE_MESH:D017379 @@@LVH@@@ regression, left atrial diameter, @DISEASE_Atrial_Fibrillation @DISEASE_MESH:D001281 @@@atrial fibrillation@@@, brain natriuretic peptide, vascular structure, @DISEASE_Thrombosis @DISEASE_MESH:D013927 @@@thrombus@@@ formation/@<m>DISEASE_Blood_Platelet_Disorders</m> @DISEASE_MESH:D001791 @@@platelet aggregation@@@, serum @CHEMICAL_Uric_Acid @CHEMICAL_MESH:D014527 @@@uric acid@@@, @DISEASE_Albuminuria @DISEASE_MESH:D000419 @@@albuminuria@@@, new-onset @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@, and @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@ metabolism. ", "citations": {"NLM": "Devereux RB, Dahlöf B. Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study. Curr Med Res Opin. 2007 Feb;23(2):443-57. PMID: 17288698", "BibTeX": "@article{17288698, title={Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.}, author={Devereux RB and Dahlöf B}, journal={Curr Med Res Opin}, volume={23}, number={2}, pages={443-57}}"}}, {"_id": "7913320", "pmid": 7913320, "title": "The role of intracellular calcium in A-23187 stimulated and beta-adrenoceptor blocking drug treated blood platelets.", "journal": "Biochem Pharmacol", "authors": ["Nosál R", "Jancinová V", "Petríková M"], "date": "1994-06-15T00:00:00Z", "doi": "10.1016/0006-2952(94)90257-7", "meta_date_publication": "1994 Jun 15", "meta_volume": "47", "meta_issue": "12", "meta_pages": "2207-11", "score": 50042.254, "text_hl": "In the absence of extracellular @CHEMICAL_Calcium @CHEMICAL_MESH:D002118 @@@calcium@@@ ions the following rank order of potency to inhibit @CHEMICAL_Calcium @CHEMICAL_MESH:D002118 @@@calcium@@@ ionophore stimulated @<m>DISEASE_Blood_Platelet_Disorders</m> @DISEASE_MESH:D001791 @@@platelet aggregation@@@ was shown: @CHEMICAL_Propranolol @CHEMICAL_MESH:D011433 @@@propranolol@@@ > @CHEMICAL_bevantolol @CHEMICAL_MESH:C021148 @@@bevantolol@@@ > @CHEMICAL_Alprenolol @CHEMICAL_MESH:D000526 @@@alprenolol@@@ > @CHEMICAL_Metipranolol @CHEMICAL_MESH:D014290 @@@metipranolol@@@ > @CHEMICAL_Oxprenolol @CHEMICAL_MESH:D010096 @@@oxprenolol@@@ > @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ > @CHEMICAL_Pindolol @CHEMICAL_MESH:D010869 @@@pindolol@@@ > @CHEMICAL_Metoprolol @CHEMICAL_MESH:D008790 @@@metoprolol@@@ approximately @CHEMICAL_Sotalol @CHEMICAL_MESH:D013015 @@@sotalol@@@ approximately @CHEMICAL_Practolol @CHEMICAL_MESH:D011217 @@@practolol@@@. ", "citations": {"NLM": "Nosál R, Jancinová V, Petríková M. The role of intracellular calcium in A-23187 stimulated and beta-adrenoceptor blocking drug treated blood platelets. Biochem Pharmacol. 1994 Jun 15;47(12):2207-11. PMID: 7913320", "BibTeX": "@article{7913320, title={The role of intracellular calcium in A-23187 stimulated and beta-adrenoceptor blocking drug treated blood platelets.}, author={Nosál R and Jancinová V and Petríková M}, journal={Biochem Pharmacol}, volume={47}, number={12}, pages={2207-11}}"}}]}